₹-5.88
(Market cap
₹881 Cr
Recently Viewed
Clear AllMarket cap
₹881 Cr
Revenue (TTM)
₹277 Cr
P/E Ratio
153
P/B Ratio
1.9
Div. Yield
0 %
Quality Score
0/0
Growth Score
0/0
Valuation Score
0/0
Momentum Score
0/0
Today’s Range
52 Week Range
Liquidity
Net Profit (TTM)
₹6 Cr
ROE
1.2 %
ROCE
0.3 %
Industry P/E
37.53
EV/EBITDA
54.2
Debt to Equity
0
Book Value
₹83.5
EPS
₹1.1
Face value
10
Shares outstanding
54,245,455
CFO
₹544.68 Cr
EBITDA
₹789.04 Cr
Net Profit
₹586.22 Cr
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Quick Heal
| -38.8 | 19.6 | -15.0 | -44.2 | 5.4 | -3.4 | -4.2 |
|
BSE IT
| -24.9 | -1.6 | -25.1 | -20.6 | 1.2 | 1.0 | 9.3 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Quick Heal
| -59.7 | 85.0 | 106.6 | -29.4 | 43.3 | 32.4 | -40.1 |
|
BSE Small Cap
| -6.6 | 29.0 | 47.5 | -1.8 | 62.8 | 32.1 | -6.8 |
|
BSE IT
| -14.9 | 19.8 | 25.6 | -24.2 | 56.1 | 56.7 | 9.8 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Quick Heal
|
162.7 | 881.5 | 277.4 | 5.8 | -7.9 | 1.3 | 153 | 1.9 |
| 921.9 | 5,050.3 | 472.6 | 140.6 | 30.1 | 16.3 | 38.3 | 5.9 | |
| 873.1 | 9,693.0 | 7,268.2 | 474.3 | 8.7 | 8.6 | 22.7 | 1.7 | |
| 688.7 | 9,635.2 | 2,917.1 | 360.8 | 14.0 | 13.4 | 26.7 | 3.2 | |
| 709.6 | 19,447.8 | 6,272.3 | 737.0 | 15.7 | 24.7 | 27 | 5.7 | |
| 236.7 | 4,172.5 | 145.7 | 139.8 | -15.9 | 15.7 | 31.9 | 11.8 | |
| 3,824.8 | 21,822.5 | 1,824.5 | 178.2 | 12.8 | 32.1 | 122.4 | 33.5 | |
| 589.9 | 6,927.5 | 1,368.7 | 179.2 | 14.4 | 12.1 | 38.7 | 3.8 | |
| 257.0 | 7,206.9 | 10,782.3 | 441.4 | 5.6 | 26.7 | 16.3 | 3.8 | |
| 1,674.4 | 15,139.4 | 834.6 | 285.4 | 37.3 | 15 | 57.6 | 8.2 |
Are these companies really bargains?
2 min read•By Danish Khanna
How did MFs fare as anchor investors?
4 min read•By Kumar Shankar Roy
Quick Heal Technologies Limited engages in the provision of security software products and solutions to consumers, small businesses, government establishments, and corporate houses in India and internationally. It offers antivirus solutions,... including total security, internet security, antivirus pro, security for mac, total security for android, mobile security, total security multi-device, and internet security essentials under the Quick Heal brand, as well as consumer fraud prevention products comprising the Quick Heal AntiFraud.AI. The company also provides endpoint protection, endpoint detection and response, extended detection and response, mobile device management, BYOD, zero trust network access, and data privacy, as well as malware analysis platform and threat intel under the Seqrite brand. In addition, it offers enterprise services, including DPDP compliance and managed detection and response. Quick Heal Technologies Limited was incorporated in 1995 and is headquartered in Pune, India. Read more
Incorporated
1995
Chairman
Kailash Katkar
Managing Director
Kailash Katkar
Headquarters
Pune, Maharashtra
Website
Looking for more details about Quick Heal Technologies Ltd.’s IPO? Explore our IPO Details page.
Our rating system has guided millions of investors in the past 20 years.
Annual Reports
The share price of Quick Heal Technologies Ltd is ₹162.68 (NSE) and ₹162.50 (BSE) as of 24-Apr-2026 IST. Quick Heal Technologies Ltd has given a return of 5.43% in the last 3 years.
The P/E ratio of Quick Heal Technologies Ltd is 153.04 times as on 24-Apr-2026, a 308 premium to its peers’ median range of 37.53 times.
The P/B ratio of Quick Heal Technologies Ltd is 1.95 times as on 24-Apr-2026, a 40 discount to its peers’ median range of 3.23 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
307.24
|
3.63
|
|
2024
|
103.91
|
5.90
|
|
2023
|
110.45
|
1.72
|
|
2022
|
12.38
|
1.66
|
|
2021
|
11.20
|
1.60
|
The 52-week high and low of Quick Heal Technologies Ltd are Rs 416.70 and Rs 125.00 as of 25-Apr-2026.
Quick Heal Technologies Ltd has a market capitalisation of ₹ 881 Cr as on 24-Apr-2026. As per SEBI classification, it is a Small Cap company.
Before investing in Quick Heal Technologies Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.